Webinar - EU developments in pricing and reimbursement
Author
Browse this blog post
Related news and insights
Blog Post: 03 April 2024
European Commission opens unprecedented abuse of dominance probe in animal medicines sector
Blog Post: 28 March 2024
Publications: 14 March 2024
Infringing gin part II: Court of Appeal victory for M&S against Aldi’s copycat design
News: 09 February 2024
Allen & Overy advises Sartorius group on EUR1.4bn equity raising
In this webinar, our Life Sciences Regulatory experts will take a closer look at the EU Health Technology Assessment (HTA) Regulation and update you on the most recent developments and legislative changes on pricing and reimbursement in Germany, Belgium and France.
Join the team on 30 November 2022 at 9am (EST) / 2pm (GMT) / 3pm (CET) where they will discuss the current status of the implemented / proposed reforms and the potential changes that might impact your business, including:
- The EU HTA Regulation and its approach of harmonising HTA;
- The German (draft) bill on the financial stabilisation of the statutory health insurance (Finanzstabilisierunsgesetz -GKV-FinStG), focussing on the proposed changes of the pricing and reimbursement system;
- Recent cases from the Beneluxa initiative and expected developments in (joint) pricing and reimbursement negotiations; and
- Developments in France regarding biosimilar / hybrid substitution and reimbursement
Please contact marie-claire.leung@allenovery.com if you would like to attend the webinar.